Associated Papers
Amino- and Carboxyl-Terminal CCR5 Mutations in Brazilian HIV-1-Infected Women and Homology Model of p.L55Q CCR5 Mutant.
Costa GC et al.
Aids Research and Human Retroviruses, 2015
Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications.
Tao YX
Pharmacology & Therapeutics, 2006
Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.
Dong HF et al.
Genes and Immunity, 2005
The differential sensitivity of human and rhesus macaque CCR5 to small-molecule inhibitors of human immunodeficiency virus type 1 entry is explained by a single amino acid difference and suggests a mechanism of action for these inhibitors.
Billick E et al.
Journal of Virology, 2004
Multiple nonfunctional alleles of CCR5 are frequent in various human populations.
Blanpain C et al.
Blood, 2000
Sequence evolution of the CCR5 chemokine receptor gene in primates.
Zhang YW et al.
Molecular Biology and Evolution, 1999
Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function.
Howard OM et al.
The Journal of Biological Chemistry, 1999
Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences.
Carrington M et al.
Human Molecular Genetics, 1999
Novel alleles of the chemokine-receptor gene CCR5.
Carrington M et al.
American Journal of Human Genetics, 1997
Association of the CCR5Δ32 Mutant Genotype with Sickle Cell Disease in Egyptian Patients.
El Sissy MH et al.
Hemoglobin, 0
Select a paper to view details